USADA Revises Rules On PEDS
Nate Diaz is an agent of change, as his threats of walking out of this month’s UFC 244 main event due to an abnormal finding in a USADA test.
Per a report from MMA Fighting, eight different substances have been added to a policy that will allow “atypical findings” that are cause for concern, and not an indicator of an intent to cheat.
Below is a list of substances, as well as threshold levels, that qualify as atypical findings.
• Clomiphene: 0.1 ng/mL1
• Dehydrochloromethyltestosterone (DHCMT) long-term metabolite (M3): 0.1 ng/mL
• Hydrochlorothiazide (HCTZ) and metabolites, Torsemide: 20 ng/mL (Out-of-Competition only)
• Selective Androgen Receptor Modulators (SARMs): 0.1 ng/mL2
• GW-1516 (GW-501516) metabolites: 0.1 ng/mL
• Epitrenbolone (Trenbolone metabolite): 0.2 ng/mL
• Zeranol: 1 ng/mL
• Zilpaterol: 1 ng/mL
Fighters who are found with those substances within the threshold will not be given a provisional suspension and will be allowed to fight while USADA continues its investigation.
“It’s a great evolution of the program and we’re actually hopeful other sports who are interested in protecting clean athletes more effectively and creating fairer systems, this will be the model for it and something we’ve been pushing both the World Anti-Doping Agency (WADA) and other programs for the past couple of years to try and do something along these lines,” USADA CEO Travis Tygart told MMA Fighting. “We’re excited about this next step and where this can lead anti-doping hopefully.”
Report: MMA Fighting